Navigation Links
2-step ovarian cancer immunotherapy made from patients' own tumor shows promise
Date:4/6/2013

WASHINGTON, D.C. As many as three quarters of advanced ovarian cancer patients appeared to respond to a new two-step immunotherapy approach -- including one patient who achieved complete remission -- according research from the Perelman School of Medicine at the University of Pennsylvania that will be presented today in a press conference at the AACR Annual Meeting 2013 (Presentation #LB-335).

The immunotherapy has two steps a personalized dendritic cell vaccination and adoptive T-cell therapy. The team reports that in the study of 31 patients, vaccination therapy alone showed about a 61 percent clinical benefit, and the combination of both therapies showed about a 75 percent benefit.

The findings offer new hope for the large number of ovarian cancer patients who relapse following treatment. The first step of the immunotherapy approach is to preserve the patient's tumor cells alive, using sterile techniques at the time of surgery so they can be used to manufacture a personalized vaccine that teaches the patient's own immune system to attack the tumor. Then, the Penn Medicine team isolates immune cells called dendritic cells from patients' blood through a process called apheresis, which is similar to the process used for blood donation. Researchers then prepare each patient's personalized vaccine by exposing her dendritic cells to the tumor tissue that was collected during surgery.

Because ovarian cancer symptoms can be stealth and easily mistaken for other issues constipation, weight gain, bloating, or more frequent urination more than 60 percent of patients are diagnosed only after the disease has spread to their lymph nodes or other distant sites in the body, when treatment is much less likely to produce a cure compared to when the disease is detected early. As the fifth leading cause of cancer-related deaths among women in the United States, it takes the lives of more than 14,000 women each year.

"Given these grim ou
'/>"/>

Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-200-2313
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. 12-Step Meetings May Help Teens Beat Alcohol, Drug Abuse
2. 2-step immunotherapy attacks advanced ovarian cancer
3. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
4. U.S. Panel Rejects Ovarian Cancer Screening
5. UC Irvine study finds racial, economic disparities in ovarian cancer care, survival
6. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
7. The prevention of hereditary breast and ovarian cancer by PGD is feasible
8. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
9. Ovarian Transplants May Preserve Fertility in Young Cancer Survivors
10. Benefit of PET and PET/CT in ovarian cancer is not proven
11. Mechanisms of acquired chemoresistance in ovarian cancer identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... The partners of Urgent Care of Westchester and ... Laser Med Spa with a special event. Residents of Westchester ... 12–7 p.m. on April 24 on 909 Midland Ave. in ... Participants will also get the chance to win free services ... any purchase, as well as up to 40 percent discounts ...
(Date:4/20/2015)... Tampa, Florida (PRWEB) April 20, 2015 ... Medicine’s Academy for Quality and Safety Improvement as the ... was presented at the association’s Annual Meeting, April 18, ... professionals work as a team, patient safety can be ... the association's president and CEO. “Northwestern Medicine and its ...
(Date:4/20/2015)... 2015 “Consumers deserve to know that their ... children’s hair will not put their health at risk,” said ... National Alliance for Hispanic Health, the nation’s leading Hispanic health ... not had authority to ensure cosmetic and personal care products ... had authority to get products off the shelves if they ...
(Date:4/20/2015)... April 20, 2015 The normal response from ... nothing more we could do.” Especially if the patient sought ... the response should be much different. So it’s critical the ... more can be done?” , Not every emergency room ... something that can be done.” But, according to Ronald ...
(Date:4/20/2015)... Florida Hospital at Connerton Long Term Acute ... Select Medical, during the annual ceremony hosted at the ... Operating Officer, Debi Martoccio, received the Leadership Award for ... six recipients out of 113 hospitals nationwide. The hospital ... the contributions to the community as well as a ...
Breaking Medicine News(10 mins):Health News:Bella Diosa Says Hello to Yonkers Community with Spa Party 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 3Health News:Statement of National Alliance for Hispanic Health on Senate Introduction of Personal Care Products Safety Act 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 3Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3
... What: , The AACR 100th Annual Meeting will feature ... research. This year,s meeting focuses on innovative research, novel ... new approaches to cancer prevention. , To help you ... and related scientific abstracts will be available online at ...
... - Introducing the First and Only Non-Drowsy Allergy ... , KENILWORTH, N.J., Jan. 14 Schering-Plough ... the introduction of new CLARITIN(R) Liqui-Gels(R), the first ... liquid-filled capsule. Now available over-the-counter, CLARITIN(R) Liqui-Gels(R) provide ...
... 14 GLG Life Tech,Corporation (TSX: GLG) ("GLG" or ... including the growth of stevia plant leaf and high ... its 500 metric ton,(MT) high grade stevia processing line ... 97"). This line, located at the Company,s Qingdao,factory ...
... book-mark site,BETHESDA, Md., Jan. 14 The American Thoracic ... site -- www.cff.org -- the top online ... of the Web" review of 2008, the American Thoracic ... fibrosis. , , "This is an ...
... Coconut Scrub Added to Specialty Line for Tweens and ... offers girls of all ages clarifying products that are ... cause redness and irritation. The products include the Everyday ... all of which will be debuting at the New ...
... Accolate and Zyflo show no behavioral changes in ... continue , , WEDNESDAY, Jan. 14 (HealthDay News) -- An ... possible suicidal behavior among those taking asthma drugs has ... officials said Tuesday. , The FDA, which began the ...
Cached Medicine News:Health News:AACR 100th annual meeting 2009 2Health News:New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available 2Health News:New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available 3Health News:GLG Life Tech Corporation Announces Upgrade to 500 Metric Ton Processing Line for Increased Rebiana Output; Design Completed for Additional 2,000 Metric Tons 2Health News:GLG Life Tech Corporation Announces Upgrade to 500 Metric Ton Processing Line for Increased Rebiana Output; Design Completed for Additional 2,000 Metric Tons 3Health News:Cystic Fibrosis Foundation Web Site Rated 'Best of the Web' 2Health News:Glory for Girls Announces All-Natural Clarifying Products for Clear and Radiant Skin 2Health News:FDA Finds No Link So Far Between Asthma Drugs and Suicide Risk 2Health News:FDA Finds No Link So Far Between Asthma Drugs and Suicide Risk 3
(Date:4/20/2015)... 20, 2015 Research published today in the ... (PNAS) demonstrates that technology invented by researchers ... Eye Institute can improve the clinical management ... tomography (OCT) angiography could largely replace current dye-based ... OHSU researchers found that OCT angiography has ...
(Date:4/20/2015)... Ireland , April 20, 2015 ... that Charles M. Mayr , Chief Communications ... due to health reasons.  In conjunction with Mayr,s ... will assume the role of Chief Communications Officer, ... Kelly served as Senior Vice President, Chief Communications ...
(Date:4/20/2015)... Mass. , April 20, 2015 ... and final clinical results for the Phase 1 ... in HER2-positive metastatic breast cancer.  The results were ... clinical trials plenary oral session at the 2015 ... in Philadelphia, PA. Data ...
Breaking Medicine Technology:Study shows new technology may improve management of leading causes of blindness 2Study shows new technology may improve management of leading causes of blindness 3Study shows new technology may improve management of leading causes of blindness 4Study shows new technology may improve management of leading causes of blindness 5Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 2Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 4Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 5
... Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a ... be participating in the 2011 Credit Suisse Annual Health ... in Phoenix, Arizona on November 9, 2011, at 8:00 ... of the presentation can be accessed via Zimmer,s Investor ...
... Leading academic and industry specialists to meet ... that could see R&D grind to a halt and the ... and screening the correct polymorphs and ensuring the characterisation of ... never been more vital. According to George Tranter from Chiralabs, ...
Cached Medicine Technology:Zimmer Holdings to Present at 2011 Credit Suisse Annual Health Care Conference 2Pharma Industry Unites With Academia to Tackle Ongoing Problem 2
Steerable catheter that is ideal for mapping unusual anatomy...
... The LASSO Circular Mapping Catheter from Biosense ... of circumferentially mapping the myocardial sleeves around ... allows the sequential assessment of PV potentials ... isolation. The circular LASSO curve with ...
Standard Deflectable Catheters...
... The reliable, easy-to-steer Bart EPXT ... shaft stability and curve control for ... point-of-tip actuation control supplies exceptional levels ... extraordinary family of small, medium and ...
Medicine Products: